Moran Kyle
SEC CIK 1657765 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WVE | Wave Life Sciences, Inc. | CFO | 134.4K | — | $4.65M | 13 | 2022-02-16 | 2026-02-09 |
Most active insiders at WVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $54.63M | — |
| 2 | GSK plc | 10% | $27.93M | — |
| 3 | Francis Chris | See Remarks | — | $7.10M |
| 4 | Moran Kyle | CFO | — | $4.15M |
| 5 | Tan Aik Na | Dir | — | $1.83M |
| 6 | HENRY CHRISTIAN O | Dir | — | $1.37M |
| 7 | Rawcliffe Adrian | Dir | — | $806.6K |
| 8 | Verdine Gregory L. | Dir | — | $269.5K |
| 9 | Wagner Heidi L | Dir | — | $231.1K |
| 10 | CORRIGAN MARK | Dir | — | $217.3K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-11 | 2026-02-05 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | A - Grant | $0.00 | +45.6K | 138.0K | +49% | $0 |
| D | 2026-02-11 | 2026-02-09 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $13.45 | -3,588 | 134.4K | -3% | -$48.3K |
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | M - OptEx | $5.20 | +296.0K | 189.2K | New | +$1.54M |
| DMT | 2025-12-10 | 2025-12-08+ | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale+OE | $15.78 | -260.0K | 89.2K | -74% | -$4.10M |
| D | 2025-02-06 | 2025-02-04 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | A - Grant | $0.00 | +42.0K | 89.2K | +89% | $0 |
| D | 2024-10-11 | 2024-10-11 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | M - OptEx | $2.48 | +25.0K | 44.8K | +126% | +$62.0K |
| T | 2024-09-27 | 2024-09-25 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $9.00 | -17.1K | 19.8K | -46% | -$154.3K |
| T | 2024-04-05 | 2024-04-03 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $6.17 | -15.6K | 33.9K | -32% | -$96.4K |
| 2023-08-23 | 2023-08-23 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $4.75 | -37.1K | 46.1K | -45% | -$176.0K | |
| D | 2023-02-17 | 2023-02-16 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $4.04 | -9,729 | 79.8K | -11% | -$39.3K |
| 2022-05-06 | 2022-05-04 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | A - Grant | $0.00 | +15.0K | 89.6K | +20% | $0 | |
| 2022-05-06 | 2022-05-05 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $1.72 | -5,021 | 84.6K | -6% | -$8,636 | |
| 2022-02-18 | 2022-02-16 | WVE | Wave Life Sciences, Inc. | Moran Kyle | CFO | S - Sale | $2.31 | -9,204 | 74.6K | -11% | -$21.3K |
Purchase Sale Sale after option exercise All abbreviations